PARSIPPANY, N.J.--(BUSINESS WIRE)--More patients die from pancreatic cancer than breast cancer, making pancreatic cancer the third leading cause of cancer-related death in the United States. Additionally, only 8 percent of patients live five years. To change the course of this disease, the Northern New Jersey Affiliate of the Pancreatic Cancer Action Network is inviting the community to attend PurpleStride New Jersey.
The event takes place during Pancreatic Cancer Awareness Month on Sunday, Nov. 13, at Mack Cali Business Campus in Parsippany, days before World Pancreatic Cancer Day on Nov. 17. PurpleStride will raise much needed awareness and funds to support the mission of the Pancreatic Cancer Action Network to advance research, support patients and create hope.
To register and to learn more visit www.purplestride.org/newjersey.
“After losing my dad to pancreatic cancer in 2011, I have been dedicated to raising awareness and funds for this unrelenting disease,” stated Dana Quinn, PurpleStride Chair of the Northern New Jersey Affiliate of the Pancreatic Cancer Action Network and this year’s recipient of the Randy Pausch Award. “Vice President Joe Biden put a stake in the ground when he announced the Moonshot initiative which focuses on advancements in cancer. New Jersey will come together to support this national initiative in hopes of achieving our goal doubling pancreatic cancer survival by 2020.”
The family-friendly 5K timed awareness walk/run will include:
- Registration opens at 7:30 a.m.; event begins at 9 a.m.
- Kid-friendly activities and “purple play zone”
- Opening ceremony featuring live entertainment
- Hosted by ABC 7’s Eyewitness News This Morning anchor Ken Rosato
- National Presenting Sponsor: Celgene
- Gold Media Sponsors: WABC-TV, WCBS NewsRadio 880, WFAN Sports Radio
- National Silver Sponsor: AbbVie
- Silver Sponsor: Rutgers Cancer Institute of New Jersey
The American Cancer Society reports an estimated 53,070 Americans will be diagnosed with pancreatic cancer and approximately 41,780 will die from the disease this year. The Pancreatic Cancer Action Network is working to double survival by 2020 by continuing to directly fund research, advocate for increased funding and resources from the national government, raise awareness through community outreach, and provide excellent patient services and support for novel initiatives like Clinical Trial Finder, Know Your TumorSM personalized medicine service and the Patient Registry.
Learn more about how you can support your local New Jersey Affiliate and the Pancreatic Cancer Action Network by visiting www.pancan.org. Click to view this year’s PurpleStride PSA and organizational PSA.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase survival for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double Pancreatic Cancer Survival by 2020. To continue to accelerate progress, a goal to raise $200 million by 2020 is also in place. Together, we can Wage Hope and rewrite the future of pancreatic cancer.
Members of the media are invited to attend the event, interview and photograph participants, volunteers and special guests. Please contact Lee at firstname.lastname@example.org to receive further press instructions.